Pacific Biosciences of California, Inc. (PACB)
1.37
-0.01
(-0.72%)
USD |
NASDAQ |
Sep 18, 16:00
1.35
-0.02
(-1.46%)
After-Hours: 20:00
Pacific Biosciences of California Research and Development Expense (TTM) : 92.16M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 92.16M |
| March 31, 2026 | 87.86M |
| December 31, 2025 | 95.21M |
| September 30, 2025 | 99.79M |
| June 30, 2025 | 98.66M |
| March 31, 2025 | 112.52M |
| December 31, 2024 | 129.02M |
| September 30, 2024 | 146.10M |
| June 30, 2024 | 168.10M |
| March 31, 2024 | 181.69M |
| December 31, 2023 | 187.17M |
| September 30, 2023 | 185.25M |
| June 30, 2023 | 184.83M |
| March 31, 2023 | 189.00M |
| December 31, 2022 | 193.00M |
| September 30, 2022 | 192.95M |
| June 30, 2022 | 173.37M |
| March 31, 2022 | 145.29M |
| December 31, 2021 | 112.90M |
| September 30, 2021 | 87.75M |
| June 30, 2021 | 76.71M |
| March 31, 2021 | 69.45M |
| December 31, 2020 | 64.15M |
| September 30, 2020 | 61.00M |
| June 30, 2020 | 59.50M |
| Date | Value |
|---|---|
| March 31, 2020 | 59.40M |
| December 31, 2019 | 59.63M |
| September 30, 2019 | 61.62M |
| June 30, 2019 | 61.01M |
| March 31, 2019 | 61.77M |
| December 31, 2018 | 62.59M |
| September 30, 2018 | 61.96M |
| June 30, 2018 | 63.44M |
| March 31, 2018 | 64.66M |
| December 31, 2017 | 65.32M |
| September 30, 2017 | 65.95M |
| June 30, 2017 | 67.59M |
| March 31, 2017 | 68.23M |
| December 31, 2016 | 67.62M |
| September 30, 2016 | 66.11M |
| June 30, 2016 | 64.80M |
| March 31, 2016 | 62.32M |
| December 31, 2015 | 60.44M |
| September 30, 2015 | 58.02M |
| June 30, 2015 | 53.55M |
| March 31, 2015 | 50.94M |
| December 31, 2014 | 48.23M |
| September 30, 2014 | 47.03M |
| June 30, 2014 | 44.42M |
| March 31, 2014 | 43.66M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Illumina, Inc. | 963.00M |
| Danaher Corp. | 1.615B |
| Thermo Fisher Scientific, Inc. | 1.403B |
| Waters Corp. | 319.74M |
| Agilent Technologies, Inc. | 480.00M |